GlassScriptPhysician profile
Benjamin Stahl
NPI 1760771901
$7,470.84
in general payments reported to CMS, 2019-2025
27 companies · $5,335 in 2025
The $5,335 reported for 2025 was more than what 91% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $251 · 2020: $181 · 2021: $501 · 2022: $497 · 2023: $396 · 2024: $309 · 2025: $5,335.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,000 · Food and Beverage: $1,966 · Travel and Lodging: $1,074.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,000.00 |
| Food and Beverage | $1,966.26 |
| Travel and Lodging | $1,074.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,050.94 | 2019-2025 | Da Vinci Surgical System |
| Medtronic, INC. | $1,792.76 | 2022-2025 | Progrip, Transorb, Maxtack |
| Stryker Corporation | $335.18 | 2019-2021 | |
| Ethicon US, LLC | $159.03 | 2019-2024 | Enseal, Dermabond Prineo, Echelon Endopath |
| Davol INC. | $136.88 | 2020-2023 | Phasix Mesh |
| Abbvie INC. | $125.00 | 2025 | |
| Baxter Healthcare | $116.67 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $94.37 | 2021-2025 | Gattex |
| Tela Bio, INC. | $60.95 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Acell, INC. | $59.04 | 2020 | |
| Conmed Corporation | $56.53 | 2024 | Airseal |
| Braintree Laboratories, INC. | $54.20 | 2023 | Suflave, Sutab |
| Innocoll Pharmaceuticals Limited | $53.17 | 2022 | |
| Axonics, INC. | $48.04 | 2023-2024 | Axonics |
| Smith+Nephew, INC. | $44.22 | 2025 | Stravix |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $41.02 | 2024 | Andexxa |
| Biotissue Holdings INC. | $31.93 | 2024 | |
| Coloplast Corp | $29.21 | 2023 | Sensura Mio |
| Boston Scientific Corporation | $28.48 | 2024 | Spyglass Discover |
| Kerecis Limited | $25.86 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Laborie Medical Technologies Corp. | $23.25 | 2024 | Eclipse |
| Kls-Martin L.P. | $20.21 | 2021 | |
| Polynovo North America LLC | $20.16 | 2022 | |
| Portola Pharmaceuticals, LLC | $18.80 | 2020 | |
| Heron Therapeutics, INC. | $17.39 | 2021 | |
| Teleflex LLC | $15.02 | 2020 | |
| Allergan, INC. | $12.53 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Stahl listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.